Global Dabigatran Etexilate Mesylate API Supply, Demand and Key Producers, 2023-2029
The global Dabigatran Etexilate Mesylate API market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Dabigatran Etexilate Mesylate API production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Dabigatran Etexilate Mesylate API, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Dabigatran Etexilate Mesylate API that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Dabigatran Etexilate Mesylate API total production and demand, 2018-2029, (Tons)
Global Dabigatran Etexilate Mesylate API total production value, 2018-2029, (USD Million)
Global Dabigatran Etexilate Mesylate API production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Dabigatran Etexilate Mesylate API consumption by region & country, CAGR, 2018-2029 & (Tons)
U.S. VS China: Dabigatran Etexilate Mesylate API domestic production, consumption, key domestic manufacturers and share
Global Dabigatran Etexilate Mesylate API production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Tons)
Global Dabigatran Etexilate Mesylate API production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Dabigatran Etexilate Mesylate API production by Application production, value, CAGR, 2018-2029, (USD Million) & (Tons)
This reports profiles key players in the global Dabigatran Etexilate Mesylate API market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hetero Drugs Ltd, Aurobindo Pharma Ltd, Neuland Laboratories Ltd, Zydus Lifesciences Ltd, Alkem Laboratories Ltd, Teva Pharmaceutical Industries Ltd, Lupin Ltd, Dr Reddys Laboratories Ltd and Apotex Pharmachem India Pvt Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Dabigatran Etexilate Mesylate API market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Dabigatran Etexilate Mesylate API Market, By Region:
1. How big is the global Dabigatran Etexilate Mesylate API market?
2. What is the demand of the global Dabigatran Etexilate Mesylate API market?
3. What is the year over year growth of the global Dabigatran Etexilate Mesylate API market?
4. What is the production and production value of the global Dabigatran Etexilate Mesylate API market?
5. Who are the key producers in the global Dabigatran Etexilate Mesylate API market?
6. What are the growth factors driving the market demand?
This report studies the global Dabigatran Etexilate Mesylate API production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Dabigatran Etexilate Mesylate API, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Dabigatran Etexilate Mesylate API that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Dabigatran Etexilate Mesylate API total production and demand, 2018-2029, (Tons)
Global Dabigatran Etexilate Mesylate API total production value, 2018-2029, (USD Million)
Global Dabigatran Etexilate Mesylate API production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Dabigatran Etexilate Mesylate API consumption by region & country, CAGR, 2018-2029 & (Tons)
U.S. VS China: Dabigatran Etexilate Mesylate API domestic production, consumption, key domestic manufacturers and share
Global Dabigatran Etexilate Mesylate API production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Tons)
Global Dabigatran Etexilate Mesylate API production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Dabigatran Etexilate Mesylate API production by Application production, value, CAGR, 2018-2029, (USD Million) & (Tons)
This reports profiles key players in the global Dabigatran Etexilate Mesylate API market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hetero Drugs Ltd, Aurobindo Pharma Ltd, Neuland Laboratories Ltd, Zydus Lifesciences Ltd, Alkem Laboratories Ltd, Teva Pharmaceutical Industries Ltd, Lupin Ltd, Dr Reddys Laboratories Ltd and Apotex Pharmachem India Pvt Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Dabigatran Etexilate Mesylate API market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Dabigatran Etexilate Mesylate API Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Purity?99%
- Purity<99%
- Capsule
- Others
- Hetero Drugs Ltd
- Aurobindo Pharma Ltd
- Neuland Laboratories Ltd
- Zydus Lifesciences Ltd
- Alkem Laboratories Ltd
- Teva Pharmaceutical Industries Ltd
- Lupin Ltd
- Dr Reddys Laboratories Ltd
- Apotex Pharmachem India Pvt Ltd
- Glenmark Life Sciences Ltd
- Alembic Pharmaceuticals Ltd
- Msn Laboratories Private Ltd
- Metrochem Api Private Ltd
- Lee Pharma Ltd
- Msn Life Sciences Private Ltd
- Optimus Drugs Private Ltd
- Yabao Pharmaceutical Group Co Ltd
- Acebright India Pharma Private Ltd
- Srini Pharmaceuticals Private Ltd
- Biocon Ltd
- Jubilant Generics Ltd
- Solara Active Pharma Sciences Ltd
- Piramal Pharma Ltd
- Micro Labs Ltd
- Sun Pharmaceutical Industries Ltd
- Zhejiang Huahai Pharmaceutical Co Ltd
- Sichuan Qingmu Pharmaceutical Co Ltd
- Jiangxi Synergy Pharmaceutical Co Ltd
- Changzhou Pharmaceutical Factory
- Hisun Pharmaceutical Nantong Co Ltd
1. How big is the global Dabigatran Etexilate Mesylate API market?
2. What is the demand of the global Dabigatran Etexilate Mesylate API market?
3. What is the year over year growth of the global Dabigatran Etexilate Mesylate API market?
4. What is the production and production value of the global Dabigatran Etexilate Mesylate API market?
5. Who are the key producers in the global Dabigatran Etexilate Mesylate API market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Dabigatran Etexilate Mesylate API Introduction
1.2 World Dabigatran Etexilate Mesylate API Supply & Forecast
1.2.1 World Dabigatran Etexilate Mesylate API Production Value (2018 & 2022 & 2029)
1.2.2 World Dabigatran Etexilate Mesylate API Production (2018-2029)
1.2.3 World Dabigatran Etexilate Mesylate API Pricing Trends (2018-2029)
1.3 World Dabigatran Etexilate Mesylate API Production by Region (Based on Production Site)
1.3.1 World Dabigatran Etexilate Mesylate API Production Value by Region (2018-2029)
1.3.2 World Dabigatran Etexilate Mesylate API Production by Region (2018-2029)
1.3.3 World Dabigatran Etexilate Mesylate API Average Price by Region (2018-2029)
1.3.4 North America Dabigatran Etexilate Mesylate API Production (2018-2029)
1.3.5 Europe Dabigatran Etexilate Mesylate API Production (2018-2029)
1.3.6 China Dabigatran Etexilate Mesylate API Production (2018-2029)
1.3.7 Japan Dabigatran Etexilate Mesylate API Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Dabigatran Etexilate Mesylate API Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Dabigatran Etexilate Mesylate API Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Dabigatran Etexilate Mesylate API Demand (2018-2029)
2.2 World Dabigatran Etexilate Mesylate API Consumption by Region
2.2.1 World Dabigatran Etexilate Mesylate API Consumption by Region (2018-2023)
2.2.2 World Dabigatran Etexilate Mesylate API Consumption Forecast by Region (2024-2029)
2.3 United States Dabigatran Etexilate Mesylate API Consumption (2018-2029)
2.4 China Dabigatran Etexilate Mesylate API Consumption (2018-2029)
2.5 Europe Dabigatran Etexilate Mesylate API Consumption (2018-2029)
2.6 Japan Dabigatran Etexilate Mesylate API Consumption (2018-2029)
2.7 South Korea Dabigatran Etexilate Mesylate API Consumption (2018-2029)
2.8 ASEAN Dabigatran Etexilate Mesylate API Consumption (2018-2029)
2.9 India Dabigatran Etexilate Mesylate API Consumption (2018-2029)
3 WORLD DABIGATRAN ETEXILATE MESYLATE API MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Dabigatran Etexilate Mesylate API Production Value by Manufacturer (2018-2023)
3.2 World Dabigatran Etexilate Mesylate API Production by Manufacturer (2018-2023)
3.3 World Dabigatran Etexilate Mesylate API Average Price by Manufacturer (2018-2023)
3.4 Dabigatran Etexilate Mesylate API Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Dabigatran Etexilate Mesylate API Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Dabigatran Etexilate Mesylate API in 2022
3.5.3 Global Concentration Ratios (CR8) for Dabigatran Etexilate Mesylate API in 2022
3.6 Dabigatran Etexilate Mesylate API Market: Overall Company Footprint Analysis
3.6.1 Dabigatran Etexilate Mesylate API Market: Region Footprint
3.6.2 Dabigatran Etexilate Mesylate API Market: Company Product Type Footprint
3.6.3 Dabigatran Etexilate Mesylate API Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Dabigatran Etexilate Mesylate API Production Value Comparison
4.1.1 United States VS China: Dabigatran Etexilate Mesylate API Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Dabigatran Etexilate Mesylate API Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Dabigatran Etexilate Mesylate API Production Comparison
4.2.1 United States VS China: Dabigatran Etexilate Mesylate API Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Dabigatran Etexilate Mesylate API Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Dabigatran Etexilate Mesylate API Consumption Comparison
4.3.1 United States VS China: Dabigatran Etexilate Mesylate API Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Dabigatran Etexilate Mesylate API Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Dabigatran Etexilate Mesylate API Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Dabigatran Etexilate Mesylate API Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Dabigatran Etexilate Mesylate API Production Value (2018-2023)
4.4.3 United States Based Manufacturers Dabigatran Etexilate Mesylate API Production (2018-2023)
4.5 China Based Dabigatran Etexilate Mesylate API Manufacturers and Market Share
4.5.1 China Based Dabigatran Etexilate Mesylate API Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Dabigatran Etexilate Mesylate API Production Value (2018-2023)
4.5.3 China Based Manufacturers Dabigatran Etexilate Mesylate API Production (2018-2023)
4.6 Rest of World Based Dabigatran Etexilate Mesylate API Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Dabigatran Etexilate Mesylate API Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Dabigatran Etexilate Mesylate API Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Dabigatran Etexilate Mesylate API Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Dabigatran Etexilate Mesylate API Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Purity?99%
5.2.2 Purity<99%
5.3 Market Segment by Type
5.3.1 World Dabigatran Etexilate Mesylate API Production by Type (2018-2029)
5.3.2 World Dabigatran Etexilate Mesylate API Production Value by Type (2018-2029)
5.3.3 World Dabigatran Etexilate Mesylate API Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Dabigatran Etexilate Mesylate API Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Capsule
6.2.2 Others
6.3 Market Segment by Application
6.3.1 World Dabigatran Etexilate Mesylate API Production by Application (2018-2029)
6.3.2 World Dabigatran Etexilate Mesylate API Production Value by Application (2018-2029)
6.3.3 World Dabigatran Etexilate Mesylate API Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Hetero Drugs Ltd
7.1.1 Hetero Drugs Ltd Details
7.1.2 Hetero Drugs Ltd Major Business
7.1.3 Hetero Drugs Ltd Dabigatran Etexilate Mesylate API Product and Services
7.1.4 Hetero Drugs Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Hetero Drugs Ltd Recent Developments/Updates
7.1.6 Hetero Drugs Ltd Competitive Strengths & Weaknesses
7.2 Aurobindo Pharma Ltd
7.2.1 Aurobindo Pharma Ltd Details
7.2.2 Aurobindo Pharma Ltd Major Business
7.2.3 Aurobindo Pharma Ltd Dabigatran Etexilate Mesylate API Product and Services
7.2.4 Aurobindo Pharma Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Aurobindo Pharma Ltd Recent Developments/Updates
7.2.6 Aurobindo Pharma Ltd Competitive Strengths & Weaknesses
7.3 Neuland Laboratories Ltd
7.3.1 Neuland Laboratories Ltd Details
7.3.2 Neuland Laboratories Ltd Major Business
7.3.3 Neuland Laboratories Ltd Dabigatran Etexilate Mesylate API Product and Services
7.3.4 Neuland Laboratories Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Neuland Laboratories Ltd Recent Developments/Updates
7.3.6 Neuland Laboratories Ltd Competitive Strengths & Weaknesses
7.4 Zydus Lifesciences Ltd
7.4.1 Zydus Lifesciences Ltd Details
7.4.2 Zydus Lifesciences Ltd Major Business
7.4.3 Zydus Lifesciences Ltd Dabigatran Etexilate Mesylate API Product and Services
7.4.4 Zydus Lifesciences Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Zydus Lifesciences Ltd Recent Developments/Updates
7.4.6 Zydus Lifesciences Ltd Competitive Strengths & Weaknesses
7.5 Alkem Laboratories Ltd
7.5.1 Alkem Laboratories Ltd Details
7.5.2 Alkem Laboratories Ltd Major Business
7.5.3 Alkem Laboratories Ltd Dabigatran Etexilate Mesylate API Product and Services
7.5.4 Alkem Laboratories Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Alkem Laboratories Ltd Recent Developments/Updates
7.5.6 Alkem Laboratories Ltd Competitive Strengths & Weaknesses
7.6 Teva Pharmaceutical Industries Ltd
7.6.1 Teva Pharmaceutical Industries Ltd Details
7.6.2 Teva Pharmaceutical Industries Ltd Major Business
7.6.3 Teva Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Product and Services
7.6.4 Teva Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.6.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.7 Lupin Ltd
7.7.1 Lupin Ltd Details
7.7.2 Lupin Ltd Major Business
7.7.3 Lupin Ltd Dabigatran Etexilate Mesylate API Product and Services
7.7.4 Lupin Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Lupin Ltd Recent Developments/Updates
7.7.6 Lupin Ltd Competitive Strengths & Weaknesses
7.8 Dr Reddys Laboratories Ltd
7.8.1 Dr Reddys Laboratories Ltd Details
7.8.2 Dr Reddys Laboratories Ltd Major Business
7.8.3 Dr Reddys Laboratories Ltd Dabigatran Etexilate Mesylate API Product and Services
7.8.4 Dr Reddys Laboratories Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Dr Reddys Laboratories Ltd Recent Developments/Updates
7.8.6 Dr Reddys Laboratories Ltd Competitive Strengths & Weaknesses
7.9 Apotex Pharmachem India Pvt Ltd
7.9.1 Apotex Pharmachem India Pvt Ltd Details
7.9.2 Apotex Pharmachem India Pvt Ltd Major Business
7.9.3 Apotex Pharmachem India Pvt Ltd Dabigatran Etexilate Mesylate API Product and Services
7.9.4 Apotex Pharmachem India Pvt Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Apotex Pharmachem India Pvt Ltd Recent Developments/Updates
7.9.6 Apotex Pharmachem India Pvt Ltd Competitive Strengths & Weaknesses
7.10 Glenmark Life Sciences Ltd
7.10.1 Glenmark Life Sciences Ltd Details
7.10.2 Glenmark Life Sciences Ltd Major Business
7.10.3 Glenmark Life Sciences Ltd Dabigatran Etexilate Mesylate API Product and Services
7.10.4 Glenmark Life Sciences Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Glenmark Life Sciences Ltd Recent Developments/Updates
7.10.6 Glenmark Life Sciences Ltd Competitive Strengths & Weaknesses
7.11 Alembic Pharmaceuticals Ltd
7.11.1 Alembic Pharmaceuticals Ltd Details
7.11.2 Alembic Pharmaceuticals Ltd Major Business
7.11.3 Alembic Pharmaceuticals Ltd Dabigatran Etexilate Mesylate API Product and Services
7.11.4 Alembic Pharmaceuticals Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Alembic Pharmaceuticals Ltd Recent Developments/Updates
7.11.6 Alembic Pharmaceuticals Ltd Competitive Strengths & Weaknesses
7.12 Msn Laboratories Private Ltd
7.12.1 Msn Laboratories Private Ltd Details
7.12.2 Msn Laboratories Private Ltd Major Business
7.12.3 Msn Laboratories Private Ltd Dabigatran Etexilate Mesylate API Product and Services
7.12.4 Msn Laboratories Private Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Msn Laboratories Private Ltd Recent Developments/Updates
7.12.6 Msn Laboratories Private Ltd Competitive Strengths & Weaknesses
7.13 Metrochem Api Private Ltd
7.13.1 Metrochem Api Private Ltd Details
7.13.2 Metrochem Api Private Ltd Major Business
7.13.3 Metrochem Api Private Ltd Dabigatran Etexilate Mesylate API Product and Services
7.13.4 Metrochem Api Private Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Metrochem Api Private Ltd Recent Developments/Updates
7.13.6 Metrochem Api Private Ltd Competitive Strengths & Weaknesses
7.14 Lee Pharma Ltd
7.14.1 Lee Pharma Ltd Details
7.14.2 Lee Pharma Ltd Major Business
7.14.3 Lee Pharma Ltd Dabigatran Etexilate Mesylate API Product and Services
7.14.4 Lee Pharma Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Lee Pharma Ltd Recent Developments/Updates
7.14.6 Lee Pharma Ltd Competitive Strengths & Weaknesses
7.15 Msn Life Sciences Private Ltd
7.15.1 Msn Life Sciences Private Ltd Details
7.15.2 Msn Life Sciences Private Ltd Major Business
7.15.3 Msn Life Sciences Private Ltd Dabigatran Etexilate Mesylate API Product and Services
7.15.4 Msn Life Sciences Private Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Msn Life Sciences Private Ltd Recent Developments/Updates
7.15.6 Msn Life Sciences Private Ltd Competitive Strengths & Weaknesses
7.16 Optimus Drugs Private Ltd
7.16.1 Optimus Drugs Private Ltd Details
7.16.2 Optimus Drugs Private Ltd Major Business
7.16.3 Optimus Drugs Private Ltd Dabigatran Etexilate Mesylate API Product and Services
7.16.4 Optimus Drugs Private Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Optimus Drugs Private Ltd Recent Developments/Updates
7.16.6 Optimus Drugs Private Ltd Competitive Strengths & Weaknesses
7.17 Yabao Pharmaceutical Group Co Ltd
7.17.1 Yabao Pharmaceutical Group Co Ltd Details
7.17.2 Yabao Pharmaceutical Group Co Ltd Major Business
7.17.3 Yabao Pharmaceutical Group Co Ltd Dabigatran Etexilate Mesylate API Product and Services
7.17.4 Yabao Pharmaceutical Group Co Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Yabao Pharmaceutical Group Co Ltd Recent Developments/Updates
7.17.6 Yabao Pharmaceutical Group Co Ltd Competitive Strengths & Weaknesses
7.18 Acebright India Pharma Private Ltd
7.18.1 Acebright India Pharma Private Ltd Details
7.18.2 Acebright India Pharma Private Ltd Major Business
7.18.3 Acebright India Pharma Private Ltd Dabigatran Etexilate Mesylate API Product and Services
7.18.4 Acebright India Pharma Private Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Acebright India Pharma Private Ltd Recent Developments/Updates
7.18.6 Acebright India Pharma Private Ltd Competitive Strengths & Weaknesses
7.19 Srini Pharmaceuticals Private Ltd
7.19.1 Srini Pharmaceuticals Private Ltd Details
7.19.2 Srini Pharmaceuticals Private Ltd Major Business
7.19.3 Srini Pharmaceuticals Private Ltd Dabigatran Etexilate Mesylate API Product and Services
7.19.4 Srini Pharmaceuticals Private Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Srini Pharmaceuticals Private Ltd Recent Developments/Updates
7.19.6 Srini Pharmaceuticals Private Ltd Competitive Strengths & Weaknesses
7.20 Biocon Ltd
7.20.1 Biocon Ltd Details
7.20.2 Biocon Ltd Major Business
7.20.3 Biocon Ltd Dabigatran Etexilate Mesylate API Product and Services
7.20.4 Biocon Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Biocon Ltd Recent Developments/Updates
7.20.6 Biocon Ltd Competitive Strengths & Weaknesses
7.21 Jubilant Generics Ltd
7.21.1 Jubilant Generics Ltd Details
7.21.2 Jubilant Generics Ltd Major Business
7.21.3 Jubilant Generics Ltd Dabigatran Etexilate Mesylate API Product and Services
7.21.4 Jubilant Generics Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.21.5 Jubilant Generics Ltd Recent Developments/Updates
7.21.6 Jubilant Generics Ltd Competitive Strengths & Weaknesses
7.22 Solara Active Pharma Sciences Ltd
7.22.1 Solara Active Pharma Sciences Ltd Details
7.22.2 Solara Active Pharma Sciences Ltd Major Business
7.22.3 Solara Active Pharma Sciences Ltd Dabigatran Etexilate Mesylate API Product and Services
7.22.4 Solara Active Pharma Sciences Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.22.5 Solara Active Pharma Sciences Ltd Recent Developments/Updates
7.22.6 Solara Active Pharma Sciences Ltd Competitive Strengths & Weaknesses
7.23 Piramal Pharma Ltd
7.23.1 Piramal Pharma Ltd Details
7.23.2 Piramal Pharma Ltd Major Business
7.23.3 Piramal Pharma Ltd Dabigatran Etexilate Mesylate API Product and Services
7.23.4 Piramal Pharma Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.23.5 Piramal Pharma Ltd Recent Developments/Updates
7.23.6 Piramal Pharma Ltd Competitive Strengths & Weaknesses
7.24 Micro Labs Ltd
7.24.1 Micro Labs Ltd Details
7.24.2 Micro Labs Ltd Major Business
7.24.3 Micro Labs Ltd Dabigatran Etexilate Mesylate API Product and Services
7.24.4 Micro Labs Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.24.5 Micro Labs Ltd Recent Developments/Updates
7.24.6 Micro Labs Ltd Competitive Strengths & Weaknesses
7.25 Sun Pharmaceutical Industries Ltd
7.25.1 Sun Pharmaceutical Industries Ltd Details
7.25.2 Sun Pharmaceutical Industries Ltd Major Business
7.25.3 Sun Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Product and Services
7.25.4 Sun Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.25.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
7.25.6 Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.26 Zhejiang Huahai Pharmaceutical Co Ltd
7.26.1 Zhejiang Huahai Pharmaceutical Co Ltd Details
7.26.2 Zhejiang Huahai Pharmaceutical Co Ltd Major Business
7.26.3 Zhejiang Huahai Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Product and Services
7.26.4 Zhejiang Huahai Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.26.5 Zhejiang Huahai Pharmaceutical Co Ltd Recent Developments/Updates
7.26.6 Zhejiang Huahai Pharmaceutical Co Ltd Competitive Strengths & Weaknesses
7.27 Sichuan Qingmu Pharmaceutical Co Ltd
7.27.1 Sichuan Qingmu Pharmaceutical Co Ltd Details
7.27.2 Sichuan Qingmu Pharmaceutical Co Ltd Major Business
7.27.3 Sichuan Qingmu Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Product and Services
7.27.4 Sichuan Qingmu Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.27.5 Sichuan Qingmu Pharmaceutical Co Ltd Recent Developments/Updates
7.27.6 Sichuan Qingmu Pharmaceutical Co Ltd Competitive Strengths & Weaknesses
7.28 Jiangxi Synergy Pharmaceutical Co Ltd
7.28.1 Jiangxi Synergy Pharmaceutical Co Ltd Details
7.28.2 Jiangxi Synergy Pharmaceutical Co Ltd Major Business
7.28.3 Jiangxi Synergy Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Product and Services
7.28.4 Jiangxi Synergy Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.28.5 Jiangxi Synergy Pharmaceutical Co Ltd Recent Developments/Updates
7.28.6 Jiangxi Synergy Pharmaceutical Co Ltd Competitive Strengths & Weaknesses
7.29 Changzhou Pharmaceutical Factory
7.29.1 Changzhou Pharmaceutical Factory Details
7.29.2 Changzhou Pharmaceutical Factory Major Business
7.29.3 Changzhou Pharmaceutical Factory Dabigatran Etexilate Mesylate API Product and Services
7.29.4 Changzhou Pharmaceutical Factory Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.29.5 Changzhou Pharmaceutical Factory Recent Developments/Updates
7.29.6 Changzhou Pharmaceutical Factory Competitive Strengths & Weaknesses
7.30 Hisun Pharmaceutical Nantong Co Ltd
7.30.1 Hisun Pharmaceutical Nantong Co Ltd Details
7.30.2 Hisun Pharmaceutical Nantong Co Ltd Major Business
7.30.3 Hisun Pharmaceutical Nantong Co Ltd Dabigatran Etexilate Mesylate API Product and Services
7.30.4 Hisun Pharmaceutical Nantong Co Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.30.5 Hisun Pharmaceutical Nantong Co Ltd Recent Developments/Updates
7.30.6 Hisun Pharmaceutical Nantong Co Ltd Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Dabigatran Etexilate Mesylate API Industry Chain
8.2 Dabigatran Etexilate Mesylate API Upstream Analysis
8.2.1 Dabigatran Etexilate Mesylate API Core Raw Materials
8.2.2 Main Manufacturers of Dabigatran Etexilate Mesylate API Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Dabigatran Etexilate Mesylate API Production Mode
8.6 Dabigatran Etexilate Mesylate API Procurement Model
8.7 Dabigatran Etexilate Mesylate API Industry Sales Model and Sales Channels
8.7.1 Dabigatran Etexilate Mesylate API Sales Model
8.7.2 Dabigatran Etexilate Mesylate API Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Dabigatran Etexilate Mesylate API Introduction
1.2 World Dabigatran Etexilate Mesylate API Supply & Forecast
1.2.1 World Dabigatran Etexilate Mesylate API Production Value (2018 & 2022 & 2029)
1.2.2 World Dabigatran Etexilate Mesylate API Production (2018-2029)
1.2.3 World Dabigatran Etexilate Mesylate API Pricing Trends (2018-2029)
1.3 World Dabigatran Etexilate Mesylate API Production by Region (Based on Production Site)
1.3.1 World Dabigatran Etexilate Mesylate API Production Value by Region (2018-2029)
1.3.2 World Dabigatran Etexilate Mesylate API Production by Region (2018-2029)
1.3.3 World Dabigatran Etexilate Mesylate API Average Price by Region (2018-2029)
1.3.4 North America Dabigatran Etexilate Mesylate API Production (2018-2029)
1.3.5 Europe Dabigatran Etexilate Mesylate API Production (2018-2029)
1.3.6 China Dabigatran Etexilate Mesylate API Production (2018-2029)
1.3.7 Japan Dabigatran Etexilate Mesylate API Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Dabigatran Etexilate Mesylate API Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Dabigatran Etexilate Mesylate API Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Dabigatran Etexilate Mesylate API Demand (2018-2029)
2.2 World Dabigatran Etexilate Mesylate API Consumption by Region
2.2.1 World Dabigatran Etexilate Mesylate API Consumption by Region (2018-2023)
2.2.2 World Dabigatran Etexilate Mesylate API Consumption Forecast by Region (2024-2029)
2.3 United States Dabigatran Etexilate Mesylate API Consumption (2018-2029)
2.4 China Dabigatran Etexilate Mesylate API Consumption (2018-2029)
2.5 Europe Dabigatran Etexilate Mesylate API Consumption (2018-2029)
2.6 Japan Dabigatran Etexilate Mesylate API Consumption (2018-2029)
2.7 South Korea Dabigatran Etexilate Mesylate API Consumption (2018-2029)
2.8 ASEAN Dabigatran Etexilate Mesylate API Consumption (2018-2029)
2.9 India Dabigatran Etexilate Mesylate API Consumption (2018-2029)
3 WORLD DABIGATRAN ETEXILATE MESYLATE API MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Dabigatran Etexilate Mesylate API Production Value by Manufacturer (2018-2023)
3.2 World Dabigatran Etexilate Mesylate API Production by Manufacturer (2018-2023)
3.3 World Dabigatran Etexilate Mesylate API Average Price by Manufacturer (2018-2023)
3.4 Dabigatran Etexilate Mesylate API Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Dabigatran Etexilate Mesylate API Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Dabigatran Etexilate Mesylate API in 2022
3.5.3 Global Concentration Ratios (CR8) for Dabigatran Etexilate Mesylate API in 2022
3.6 Dabigatran Etexilate Mesylate API Market: Overall Company Footprint Analysis
3.6.1 Dabigatran Etexilate Mesylate API Market: Region Footprint
3.6.2 Dabigatran Etexilate Mesylate API Market: Company Product Type Footprint
3.6.3 Dabigatran Etexilate Mesylate API Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Dabigatran Etexilate Mesylate API Production Value Comparison
4.1.1 United States VS China: Dabigatran Etexilate Mesylate API Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Dabigatran Etexilate Mesylate API Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Dabigatran Etexilate Mesylate API Production Comparison
4.2.1 United States VS China: Dabigatran Etexilate Mesylate API Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Dabigatran Etexilate Mesylate API Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Dabigatran Etexilate Mesylate API Consumption Comparison
4.3.1 United States VS China: Dabigatran Etexilate Mesylate API Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Dabigatran Etexilate Mesylate API Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Dabigatran Etexilate Mesylate API Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Dabigatran Etexilate Mesylate API Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Dabigatran Etexilate Mesylate API Production Value (2018-2023)
4.4.3 United States Based Manufacturers Dabigatran Etexilate Mesylate API Production (2018-2023)
4.5 China Based Dabigatran Etexilate Mesylate API Manufacturers and Market Share
4.5.1 China Based Dabigatran Etexilate Mesylate API Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Dabigatran Etexilate Mesylate API Production Value (2018-2023)
4.5.3 China Based Manufacturers Dabigatran Etexilate Mesylate API Production (2018-2023)
4.6 Rest of World Based Dabigatran Etexilate Mesylate API Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Dabigatran Etexilate Mesylate API Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Dabigatran Etexilate Mesylate API Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Dabigatran Etexilate Mesylate API Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Dabigatran Etexilate Mesylate API Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Purity?99%
5.2.2 Purity<99%
5.3 Market Segment by Type
5.3.1 World Dabigatran Etexilate Mesylate API Production by Type (2018-2029)
5.3.2 World Dabigatran Etexilate Mesylate API Production Value by Type (2018-2029)
5.3.3 World Dabigatran Etexilate Mesylate API Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Dabigatran Etexilate Mesylate API Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Capsule
6.2.2 Others
6.3 Market Segment by Application
6.3.1 World Dabigatran Etexilate Mesylate API Production by Application (2018-2029)
6.3.2 World Dabigatran Etexilate Mesylate API Production Value by Application (2018-2029)
6.3.3 World Dabigatran Etexilate Mesylate API Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Hetero Drugs Ltd
7.1.1 Hetero Drugs Ltd Details
7.1.2 Hetero Drugs Ltd Major Business
7.1.3 Hetero Drugs Ltd Dabigatran Etexilate Mesylate API Product and Services
7.1.4 Hetero Drugs Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Hetero Drugs Ltd Recent Developments/Updates
7.1.6 Hetero Drugs Ltd Competitive Strengths & Weaknesses
7.2 Aurobindo Pharma Ltd
7.2.1 Aurobindo Pharma Ltd Details
7.2.2 Aurobindo Pharma Ltd Major Business
7.2.3 Aurobindo Pharma Ltd Dabigatran Etexilate Mesylate API Product and Services
7.2.4 Aurobindo Pharma Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Aurobindo Pharma Ltd Recent Developments/Updates
7.2.6 Aurobindo Pharma Ltd Competitive Strengths & Weaknesses
7.3 Neuland Laboratories Ltd
7.3.1 Neuland Laboratories Ltd Details
7.3.2 Neuland Laboratories Ltd Major Business
7.3.3 Neuland Laboratories Ltd Dabigatran Etexilate Mesylate API Product and Services
7.3.4 Neuland Laboratories Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Neuland Laboratories Ltd Recent Developments/Updates
7.3.6 Neuland Laboratories Ltd Competitive Strengths & Weaknesses
7.4 Zydus Lifesciences Ltd
7.4.1 Zydus Lifesciences Ltd Details
7.4.2 Zydus Lifesciences Ltd Major Business
7.4.3 Zydus Lifesciences Ltd Dabigatran Etexilate Mesylate API Product and Services
7.4.4 Zydus Lifesciences Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Zydus Lifesciences Ltd Recent Developments/Updates
7.4.6 Zydus Lifesciences Ltd Competitive Strengths & Weaknesses
7.5 Alkem Laboratories Ltd
7.5.1 Alkem Laboratories Ltd Details
7.5.2 Alkem Laboratories Ltd Major Business
7.5.3 Alkem Laboratories Ltd Dabigatran Etexilate Mesylate API Product and Services
7.5.4 Alkem Laboratories Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Alkem Laboratories Ltd Recent Developments/Updates
7.5.6 Alkem Laboratories Ltd Competitive Strengths & Weaknesses
7.6 Teva Pharmaceutical Industries Ltd
7.6.1 Teva Pharmaceutical Industries Ltd Details
7.6.2 Teva Pharmaceutical Industries Ltd Major Business
7.6.3 Teva Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Product and Services
7.6.4 Teva Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.6.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.7 Lupin Ltd
7.7.1 Lupin Ltd Details
7.7.2 Lupin Ltd Major Business
7.7.3 Lupin Ltd Dabigatran Etexilate Mesylate API Product and Services
7.7.4 Lupin Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Lupin Ltd Recent Developments/Updates
7.7.6 Lupin Ltd Competitive Strengths & Weaknesses
7.8 Dr Reddys Laboratories Ltd
7.8.1 Dr Reddys Laboratories Ltd Details
7.8.2 Dr Reddys Laboratories Ltd Major Business
7.8.3 Dr Reddys Laboratories Ltd Dabigatran Etexilate Mesylate API Product and Services
7.8.4 Dr Reddys Laboratories Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Dr Reddys Laboratories Ltd Recent Developments/Updates
7.8.6 Dr Reddys Laboratories Ltd Competitive Strengths & Weaknesses
7.9 Apotex Pharmachem India Pvt Ltd
7.9.1 Apotex Pharmachem India Pvt Ltd Details
7.9.2 Apotex Pharmachem India Pvt Ltd Major Business
7.9.3 Apotex Pharmachem India Pvt Ltd Dabigatran Etexilate Mesylate API Product and Services
7.9.4 Apotex Pharmachem India Pvt Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Apotex Pharmachem India Pvt Ltd Recent Developments/Updates
7.9.6 Apotex Pharmachem India Pvt Ltd Competitive Strengths & Weaknesses
7.10 Glenmark Life Sciences Ltd
7.10.1 Glenmark Life Sciences Ltd Details
7.10.2 Glenmark Life Sciences Ltd Major Business
7.10.3 Glenmark Life Sciences Ltd Dabigatran Etexilate Mesylate API Product and Services
7.10.4 Glenmark Life Sciences Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Glenmark Life Sciences Ltd Recent Developments/Updates
7.10.6 Glenmark Life Sciences Ltd Competitive Strengths & Weaknesses
7.11 Alembic Pharmaceuticals Ltd
7.11.1 Alembic Pharmaceuticals Ltd Details
7.11.2 Alembic Pharmaceuticals Ltd Major Business
7.11.3 Alembic Pharmaceuticals Ltd Dabigatran Etexilate Mesylate API Product and Services
7.11.4 Alembic Pharmaceuticals Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Alembic Pharmaceuticals Ltd Recent Developments/Updates
7.11.6 Alembic Pharmaceuticals Ltd Competitive Strengths & Weaknesses
7.12 Msn Laboratories Private Ltd
7.12.1 Msn Laboratories Private Ltd Details
7.12.2 Msn Laboratories Private Ltd Major Business
7.12.3 Msn Laboratories Private Ltd Dabigatran Etexilate Mesylate API Product and Services
7.12.4 Msn Laboratories Private Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Msn Laboratories Private Ltd Recent Developments/Updates
7.12.6 Msn Laboratories Private Ltd Competitive Strengths & Weaknesses
7.13 Metrochem Api Private Ltd
7.13.1 Metrochem Api Private Ltd Details
7.13.2 Metrochem Api Private Ltd Major Business
7.13.3 Metrochem Api Private Ltd Dabigatran Etexilate Mesylate API Product and Services
7.13.4 Metrochem Api Private Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Metrochem Api Private Ltd Recent Developments/Updates
7.13.6 Metrochem Api Private Ltd Competitive Strengths & Weaknesses
7.14 Lee Pharma Ltd
7.14.1 Lee Pharma Ltd Details
7.14.2 Lee Pharma Ltd Major Business
7.14.3 Lee Pharma Ltd Dabigatran Etexilate Mesylate API Product and Services
7.14.4 Lee Pharma Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Lee Pharma Ltd Recent Developments/Updates
7.14.6 Lee Pharma Ltd Competitive Strengths & Weaknesses
7.15 Msn Life Sciences Private Ltd
7.15.1 Msn Life Sciences Private Ltd Details
7.15.2 Msn Life Sciences Private Ltd Major Business
7.15.3 Msn Life Sciences Private Ltd Dabigatran Etexilate Mesylate API Product and Services
7.15.4 Msn Life Sciences Private Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Msn Life Sciences Private Ltd Recent Developments/Updates
7.15.6 Msn Life Sciences Private Ltd Competitive Strengths & Weaknesses
7.16 Optimus Drugs Private Ltd
7.16.1 Optimus Drugs Private Ltd Details
7.16.2 Optimus Drugs Private Ltd Major Business
7.16.3 Optimus Drugs Private Ltd Dabigatran Etexilate Mesylate API Product and Services
7.16.4 Optimus Drugs Private Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Optimus Drugs Private Ltd Recent Developments/Updates
7.16.6 Optimus Drugs Private Ltd Competitive Strengths & Weaknesses
7.17 Yabao Pharmaceutical Group Co Ltd
7.17.1 Yabao Pharmaceutical Group Co Ltd Details
7.17.2 Yabao Pharmaceutical Group Co Ltd Major Business
7.17.3 Yabao Pharmaceutical Group Co Ltd Dabigatran Etexilate Mesylate API Product and Services
7.17.4 Yabao Pharmaceutical Group Co Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Yabao Pharmaceutical Group Co Ltd Recent Developments/Updates
7.17.6 Yabao Pharmaceutical Group Co Ltd Competitive Strengths & Weaknesses
7.18 Acebright India Pharma Private Ltd
7.18.1 Acebright India Pharma Private Ltd Details
7.18.2 Acebright India Pharma Private Ltd Major Business
7.18.3 Acebright India Pharma Private Ltd Dabigatran Etexilate Mesylate API Product and Services
7.18.4 Acebright India Pharma Private Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Acebright India Pharma Private Ltd Recent Developments/Updates
7.18.6 Acebright India Pharma Private Ltd Competitive Strengths & Weaknesses
7.19 Srini Pharmaceuticals Private Ltd
7.19.1 Srini Pharmaceuticals Private Ltd Details
7.19.2 Srini Pharmaceuticals Private Ltd Major Business
7.19.3 Srini Pharmaceuticals Private Ltd Dabigatran Etexilate Mesylate API Product and Services
7.19.4 Srini Pharmaceuticals Private Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Srini Pharmaceuticals Private Ltd Recent Developments/Updates
7.19.6 Srini Pharmaceuticals Private Ltd Competitive Strengths & Weaknesses
7.20 Biocon Ltd
7.20.1 Biocon Ltd Details
7.20.2 Biocon Ltd Major Business
7.20.3 Biocon Ltd Dabigatran Etexilate Mesylate API Product and Services
7.20.4 Biocon Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Biocon Ltd Recent Developments/Updates
7.20.6 Biocon Ltd Competitive Strengths & Weaknesses
7.21 Jubilant Generics Ltd
7.21.1 Jubilant Generics Ltd Details
7.21.2 Jubilant Generics Ltd Major Business
7.21.3 Jubilant Generics Ltd Dabigatran Etexilate Mesylate API Product and Services
7.21.4 Jubilant Generics Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.21.5 Jubilant Generics Ltd Recent Developments/Updates
7.21.6 Jubilant Generics Ltd Competitive Strengths & Weaknesses
7.22 Solara Active Pharma Sciences Ltd
7.22.1 Solara Active Pharma Sciences Ltd Details
7.22.2 Solara Active Pharma Sciences Ltd Major Business
7.22.3 Solara Active Pharma Sciences Ltd Dabigatran Etexilate Mesylate API Product and Services
7.22.4 Solara Active Pharma Sciences Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.22.5 Solara Active Pharma Sciences Ltd Recent Developments/Updates
7.22.6 Solara Active Pharma Sciences Ltd Competitive Strengths & Weaknesses
7.23 Piramal Pharma Ltd
7.23.1 Piramal Pharma Ltd Details
7.23.2 Piramal Pharma Ltd Major Business
7.23.3 Piramal Pharma Ltd Dabigatran Etexilate Mesylate API Product and Services
7.23.4 Piramal Pharma Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.23.5 Piramal Pharma Ltd Recent Developments/Updates
7.23.6 Piramal Pharma Ltd Competitive Strengths & Weaknesses
7.24 Micro Labs Ltd
7.24.1 Micro Labs Ltd Details
7.24.2 Micro Labs Ltd Major Business
7.24.3 Micro Labs Ltd Dabigatran Etexilate Mesylate API Product and Services
7.24.4 Micro Labs Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.24.5 Micro Labs Ltd Recent Developments/Updates
7.24.6 Micro Labs Ltd Competitive Strengths & Weaknesses
7.25 Sun Pharmaceutical Industries Ltd
7.25.1 Sun Pharmaceutical Industries Ltd Details
7.25.2 Sun Pharmaceutical Industries Ltd Major Business
7.25.3 Sun Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Product and Services
7.25.4 Sun Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.25.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
7.25.6 Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.26 Zhejiang Huahai Pharmaceutical Co Ltd
7.26.1 Zhejiang Huahai Pharmaceutical Co Ltd Details
7.26.2 Zhejiang Huahai Pharmaceutical Co Ltd Major Business
7.26.3 Zhejiang Huahai Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Product and Services
7.26.4 Zhejiang Huahai Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.26.5 Zhejiang Huahai Pharmaceutical Co Ltd Recent Developments/Updates
7.26.6 Zhejiang Huahai Pharmaceutical Co Ltd Competitive Strengths & Weaknesses
7.27 Sichuan Qingmu Pharmaceutical Co Ltd
7.27.1 Sichuan Qingmu Pharmaceutical Co Ltd Details
7.27.2 Sichuan Qingmu Pharmaceutical Co Ltd Major Business
7.27.3 Sichuan Qingmu Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Product and Services
7.27.4 Sichuan Qingmu Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.27.5 Sichuan Qingmu Pharmaceutical Co Ltd Recent Developments/Updates
7.27.6 Sichuan Qingmu Pharmaceutical Co Ltd Competitive Strengths & Weaknesses
7.28 Jiangxi Synergy Pharmaceutical Co Ltd
7.28.1 Jiangxi Synergy Pharmaceutical Co Ltd Details
7.28.2 Jiangxi Synergy Pharmaceutical Co Ltd Major Business
7.28.3 Jiangxi Synergy Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Product and Services
7.28.4 Jiangxi Synergy Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.28.5 Jiangxi Synergy Pharmaceutical Co Ltd Recent Developments/Updates
7.28.6 Jiangxi Synergy Pharmaceutical Co Ltd Competitive Strengths & Weaknesses
7.29 Changzhou Pharmaceutical Factory
7.29.1 Changzhou Pharmaceutical Factory Details
7.29.2 Changzhou Pharmaceutical Factory Major Business
7.29.3 Changzhou Pharmaceutical Factory Dabigatran Etexilate Mesylate API Product and Services
7.29.4 Changzhou Pharmaceutical Factory Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.29.5 Changzhou Pharmaceutical Factory Recent Developments/Updates
7.29.6 Changzhou Pharmaceutical Factory Competitive Strengths & Weaknesses
7.30 Hisun Pharmaceutical Nantong Co Ltd
7.30.1 Hisun Pharmaceutical Nantong Co Ltd Details
7.30.2 Hisun Pharmaceutical Nantong Co Ltd Major Business
7.30.3 Hisun Pharmaceutical Nantong Co Ltd Dabigatran Etexilate Mesylate API Product and Services
7.30.4 Hisun Pharmaceutical Nantong Co Ltd Dabigatran Etexilate Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.30.5 Hisun Pharmaceutical Nantong Co Ltd Recent Developments/Updates
7.30.6 Hisun Pharmaceutical Nantong Co Ltd Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Dabigatran Etexilate Mesylate API Industry Chain
8.2 Dabigatran Etexilate Mesylate API Upstream Analysis
8.2.1 Dabigatran Etexilate Mesylate API Core Raw Materials
8.2.2 Main Manufacturers of Dabigatran Etexilate Mesylate API Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Dabigatran Etexilate Mesylate API Production Mode
8.6 Dabigatran Etexilate Mesylate API Procurement Model
8.7 Dabigatran Etexilate Mesylate API Industry Sales Model and Sales Channels
8.7.1 Dabigatran Etexilate Mesylate API Sales Model
8.7.2 Dabigatran Etexilate Mesylate API Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Dabigatran Etexilate Mesylate API Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Dabigatran Etexilate Mesylate API Production Value by Region (2018-2023) & (USD Million)
Table 3. World Dabigatran Etexilate Mesylate API Production Value by Region (2024-2029) & (USD Million)
Table 4. World Dabigatran Etexilate Mesylate API Production Value Market Share by Region (2018-2023)
Table 5. World Dabigatran Etexilate Mesylate API Production Value Market Share by Region (2024-2029)
Table 6. World Dabigatran Etexilate Mesylate API Production by Region (2018-2023) & (Tons)
Table 7. World Dabigatran Etexilate Mesylate API Production by Region (2024-2029) & (Tons)
Table 8. World Dabigatran Etexilate Mesylate API Production Market Share by Region (2018-2023)
Table 9. World Dabigatran Etexilate Mesylate API Production Market Share by Region (2024-2029)
Table 10. World Dabigatran Etexilate Mesylate API Average Price by Region (2018-2023) & (US$/Ton)
Table 11. World Dabigatran Etexilate Mesylate API Average Price by Region (2024-2029) & (US$/Ton)
Table 12. Dabigatran Etexilate Mesylate API Major Market Trends
Table 13. World Dabigatran Etexilate Mesylate API Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Tons)
Table 14. World Dabigatran Etexilate Mesylate API Consumption by Region (2018-2023) & (Tons)
Table 15. World Dabigatran Etexilate Mesylate API Consumption Forecast by Region (2024-2029) & (Tons)
Table 16. World Dabigatran Etexilate Mesylate API Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Dabigatran Etexilate Mesylate API Producers in 2022
Table 18. World Dabigatran Etexilate Mesylate API Production by Manufacturer (2018-2023) & (Tons)
Table 19. Production Market Share of Key Dabigatran Etexilate Mesylate API Producers in 2022
Table 20. World Dabigatran Etexilate Mesylate API Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 21. Global Dabigatran Etexilate Mesylate API Company Evaluation Quadrant
Table 22. World Dabigatran Etexilate Mesylate API Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Dabigatran Etexilate Mesylate API Production Site of Key Manufacturer
Table 24. Dabigatran Etexilate Mesylate API Market: Company Product Type Footprint
Table 25. Dabigatran Etexilate Mesylate API Market: Company Product Application Footprint
Table 26. Dabigatran Etexilate Mesylate API Competitive Factors
Table 27. Dabigatran Etexilate Mesylate API New Entrant and Capacity Expansion Plans
Table 28. Dabigatran Etexilate Mesylate API Mergers & Acquisitions Activity
Table 29. United States VS China Dabigatran Etexilate Mesylate API Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Dabigatran Etexilate Mesylate API Production Comparison, (2018 & 2022 & 2029) & (Tons)
Table 31. United States VS China Dabigatran Etexilate Mesylate API Consumption Comparison, (2018 & 2022 & 2029) & (Tons)
Table 32. United States Based Dabigatran Etexilate Mesylate API Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Dabigatran Etexilate Mesylate API Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Dabigatran Etexilate Mesylate API Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Dabigatran Etexilate Mesylate API Production (2018-2023) & (Tons)
Table 36. United States Based Manufacturers Dabigatran Etexilate Mesylate API Production Market Share (2018-2023)
Table 37. China Based Dabigatran Etexilate Mesylate API Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Dabigatran Etexilate Mesylate API Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Dabigatran Etexilate Mesylate API Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Dabigatran Etexilate Mesylate API Production (2018-2023) & (Tons)
Table 41. China Based Manufacturers Dabigatran Etexilate Mesylate API Production Market Share (2018-2023)
Table 42. Rest of World Based Dabigatran Etexilate Mesylate API Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Dabigatran Etexilate Mesylate API Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Dabigatran Etexilate Mesylate API Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Dabigatran Etexilate Mesylate API Production (2018-2023) & (Tons)
Table 46. Rest of World Based Manufacturers Dabigatran Etexilate Mesylate API Production Market Share (2018-2023)
Table 47. World Dabigatran Etexilate Mesylate API Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Dabigatran Etexilate Mesylate API Production by Type (2018-2023) & (Tons)
Table 49. World Dabigatran Etexilate Mesylate API Production by Type (2024-2029) & (Tons)
Table 50. World Dabigatran Etexilate Mesylate API Production Value by Type (2018-2023) & (USD Million)
Table 51. World Dabigatran Etexilate Mesylate API Production Value by Type (2024-2029) & (USD Million)
Table 52. World Dabigatran Etexilate Mesylate API Average Price by Type (2018-2023) & (US$/Ton)
Table 53. World Dabigatran Etexilate Mesylate API Average Price by Type (2024-2029) & (US$/Ton)
Table 54. World Dabigatran Etexilate Mesylate API Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Dabigatran Etexilate Mesylate API Production by Application (2018-2023) & (Tons)
Table 56. World Dabigatran Etexilate Mesylate API Production by Application (2024-2029) & (Tons)
Table 57. World Dabigatran Etexilate Mesylate API Production Value by Application (2018-2023) & (USD Million)
Table 58. World Dabigatran Etexilate Mesylate API Production Value by Application (2024-2029) & (USD Million)
Table 59. World Dabigatran Etexilate Mesylate API Average Price by Application (2018-2023) & (US$/Ton)
Table 60. World Dabigatran Etexilate Mesylate API Average Price by Application (2024-2029) & (US$/Ton)
Table 61. Hetero Drugs Ltd Basic Information, Manufacturing Base and Competitors
Table 62. Hetero Drugs Ltd Major Business
Table 63. Hetero Drugs Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 64. Hetero Drugs Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Hetero Drugs Ltd Recent Developments/Updates
Table 66. Hetero Drugs Ltd Competitive Strengths & Weaknesses
Table 67. Aurobindo Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 68. Aurobindo Pharma Ltd Major Business
Table 69. Aurobindo Pharma Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 70. Aurobindo Pharma Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Aurobindo Pharma Ltd Recent Developments/Updates
Table 72. Aurobindo Pharma Ltd Competitive Strengths & Weaknesses
Table 73. Neuland Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Neuland Laboratories Ltd Major Business
Table 75. Neuland Laboratories Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 76. Neuland Laboratories Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Neuland Laboratories Ltd Recent Developments/Updates
Table 78. Neuland Laboratories Ltd Competitive Strengths & Weaknesses
Table 79. Zydus Lifesciences Ltd Basic Information, Manufacturing Base and Competitors
Table 80. Zydus Lifesciences Ltd Major Business
Table 81. Zydus Lifesciences Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 82. Zydus Lifesciences Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Zydus Lifesciences Ltd Recent Developments/Updates
Table 84. Zydus Lifesciences Ltd Competitive Strengths & Weaknesses
Table 85. Alkem Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 86. Alkem Laboratories Ltd Major Business
Table 87. Alkem Laboratories Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 88. Alkem Laboratories Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Alkem Laboratories Ltd Recent Developments/Updates
Table 90. Alkem Laboratories Ltd Competitive Strengths & Weaknesses
Table 91. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 92. Teva Pharmaceutical Industries Ltd Major Business
Table 93. Teva Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 94. Teva Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 96. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 97. Lupin Ltd Basic Information, Manufacturing Base and Competitors
Table 98. Lupin Ltd Major Business
Table 99. Lupin Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 100. Lupin Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Lupin Ltd Recent Developments/Updates
Table 102. Lupin Ltd Competitive Strengths & Weaknesses
Table 103. Dr Reddys Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Dr Reddys Laboratories Ltd Major Business
Table 105. Dr Reddys Laboratories Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 106. Dr Reddys Laboratories Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Dr Reddys Laboratories Ltd Recent Developments/Updates
Table 108. Dr Reddys Laboratories Ltd Competitive Strengths & Weaknesses
Table 109. Apotex Pharmachem India Pvt Ltd Basic Information, Manufacturing Base and Competitors
Table 110. Apotex Pharmachem India Pvt Ltd Major Business
Table 111. Apotex Pharmachem India Pvt Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 112. Apotex Pharmachem India Pvt Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Apotex Pharmachem India Pvt Ltd Recent Developments/Updates
Table 114. Apotex Pharmachem India Pvt Ltd Competitive Strengths & Weaknesses
Table 115. Glenmark Life Sciences Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Glenmark Life Sciences Ltd Major Business
Table 117. Glenmark Life Sciences Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 118. Glenmark Life Sciences Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Glenmark Life Sciences Ltd Recent Developments/Updates
Table 120. Glenmark Life Sciences Ltd Competitive Strengths & Weaknesses
Table 121. Alembic Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 122. Alembic Pharmaceuticals Ltd Major Business
Table 123. Alembic Pharmaceuticals Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 124. Alembic Pharmaceuticals Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Alembic Pharmaceuticals Ltd Recent Developments/Updates
Table 126. Alembic Pharmaceuticals Ltd Competitive Strengths & Weaknesses
Table 127. Msn Laboratories Private Ltd Basic Information, Manufacturing Base and Competitors
Table 128. Msn Laboratories Private Ltd Major Business
Table 129. Msn Laboratories Private Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 130. Msn Laboratories Private Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Msn Laboratories Private Ltd Recent Developments/Updates
Table 132. Msn Laboratories Private Ltd Competitive Strengths & Weaknesses
Table 133. Metrochem Api Private Ltd Basic Information, Manufacturing Base and Competitors
Table 134. Metrochem Api Private Ltd Major Business
Table 135. Metrochem Api Private Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 136. Metrochem Api Private Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Metrochem Api Private Ltd Recent Developments/Updates
Table 138. Metrochem Api Private Ltd Competitive Strengths & Weaknesses
Table 139. Lee Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 140. Lee Pharma Ltd Major Business
Table 141. Lee Pharma Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 142. Lee Pharma Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Lee Pharma Ltd Recent Developments/Updates
Table 144. Lee Pharma Ltd Competitive Strengths & Weaknesses
Table 145. Msn Life Sciences Private Ltd Basic Information, Manufacturing Base and Competitors
Table 146. Msn Life Sciences Private Ltd Major Business
Table 147. Msn Life Sciences Private Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 148. Msn Life Sciences Private Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Msn Life Sciences Private Ltd Recent Developments/Updates
Table 150. Msn Life Sciences Private Ltd Competitive Strengths & Weaknesses
Table 151. Optimus Drugs Private Ltd Basic Information, Manufacturing Base and Competitors
Table 152. Optimus Drugs Private Ltd Major Business
Table 153. Optimus Drugs Private Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 154. Optimus Drugs Private Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Optimus Drugs Private Ltd Recent Developments/Updates
Table 156. Optimus Drugs Private Ltd Competitive Strengths & Weaknesses
Table 157. Yabao Pharmaceutical Group Co Ltd Basic Information, Manufacturing Base and Competitors
Table 158. Yabao Pharmaceutical Group Co Ltd Major Business
Table 159. Yabao Pharmaceutical Group Co Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 160. Yabao Pharmaceutical Group Co Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Yabao Pharmaceutical Group Co Ltd Recent Developments/Updates
Table 162. Yabao Pharmaceutical Group Co Ltd Competitive Strengths & Weaknesses
Table 163. Acebright India Pharma Private Ltd Basic Information, Manufacturing Base and Competitors
Table 164. Acebright India Pharma Private Ltd Major Business
Table 165. Acebright India Pharma Private Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 166. Acebright India Pharma Private Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Acebright India Pharma Private Ltd Recent Developments/Updates
Table 168. Acebright India Pharma Private Ltd Competitive Strengths & Weaknesses
Table 169. Srini Pharmaceuticals Private Ltd Basic Information, Manufacturing Base and Competitors
Table 170. Srini Pharmaceuticals Private Ltd Major Business
Table 171. Srini Pharmaceuticals Private Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 172. Srini Pharmaceuticals Private Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Srini Pharmaceuticals Private Ltd Recent Developments/Updates
Table 174. Srini Pharmaceuticals Private Ltd Competitive Strengths & Weaknesses
Table 175. Biocon Ltd Basic Information, Manufacturing Base and Competitors
Table 176. Biocon Ltd Major Business
Table 177. Biocon Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 178. Biocon Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. Biocon Ltd Recent Developments/Updates
Table 180. Biocon Ltd Competitive Strengths & Weaknesses
Table 181. Jubilant Generics Ltd Basic Information, Manufacturing Base and Competitors
Table 182. Jubilant Generics Ltd Major Business
Table 183. Jubilant Generics Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 184. Jubilant Generics Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 185. Jubilant Generics Ltd Recent Developments/Updates
Table 186. Jubilant Generics Ltd Competitive Strengths & Weaknesses
Table 187. Solara Active Pharma Sciences Ltd Basic Information, Manufacturing Base and Competitors
Table 188. Solara Active Pharma Sciences Ltd Major Business
Table 189. Solara Active Pharma Sciences Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 190. Solara Active Pharma Sciences Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 191. Solara Active Pharma Sciences Ltd Recent Developments/Updates
Table 192. Solara Active Pharma Sciences Ltd Competitive Strengths & Weaknesses
Table 193. Piramal Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 194. Piramal Pharma Ltd Major Business
Table 195. Piramal Pharma Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 196. Piramal Pharma Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 197. Piramal Pharma Ltd Recent Developments/Updates
Table 198. Piramal Pharma Ltd Competitive Strengths & Weaknesses
Table 199. Micro Labs Ltd Basic Information, Manufacturing Base and Competitors
Table 200. Micro Labs Ltd Major Business
Table 201. Micro Labs Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 202. Micro Labs Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 203. Micro Labs Ltd Recent Developments/Updates
Table 204. Micro Labs Ltd Competitive Strengths & Weaknesses
Table 205. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 206. Sun Pharmaceutical Industries Ltd Major Business
Table 207. Sun Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 208. Sun Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 209. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 210. Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 211. Zhejiang Huahai Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 212. Zhejiang Huahai Pharmaceutical Co Ltd Major Business
Table 213. Zhejiang Huahai Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 214. Zhejiang Huahai Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 215. Zhejiang Huahai Pharmaceutical Co Ltd Recent Developments/Updates
Table 216. Zhejiang Huahai Pharmaceutical Co Ltd Competitive Strengths & Weaknesses
Table 217. Sichuan Qingmu Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 218. Sichuan Qingmu Pharmaceutical Co Ltd Major Business
Table 219. Sichuan Qingmu Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 220. Sichuan Qingmu Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 221. Sichuan Qingmu Pharmaceutical Co Ltd Recent Developments/Updates
Table 222. Sichuan Qingmu Pharmaceutical Co Ltd Competitive Strengths & Weaknesses
Table 223. Jiangxi Synergy Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 224. Jiangxi Synergy Pharmaceutical Co Ltd Major Business
Table 225. Jiangxi Synergy Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 226. Jiangxi Synergy Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 227. Jiangxi Synergy Pharmaceutical Co Ltd Recent Developments/Updates
Table 228. Jiangxi Synergy Pharmaceutical Co Ltd Competitive Strengths & Weaknesses
Table 229. Changzhou Pharmaceutical Factory Basic Information, Manufacturing Base and Competitors
Table 230. Changzhou Pharmaceutical FactoryMajor Business
Table 231. Changzhou Pharmaceutical Factory Dabigatran Etexilate Mesylate API Product and Services
Table 232. Changzhou Pharmaceutical Factory Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 233. Changzhou Pharmaceutical Factory Recent Developments/Updates
Table 234. Hisun Pharmaceutical Nantong Co Ltd Basic Information, Manufacturing Base and Competitors
Table 235. Hisun Pharmaceutical Nantong Co Ltd Major Business
Table 236. Hisun Pharmaceutical Nantong Co Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 237. Hisun Pharmaceutical Nantong Co Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 238. Global Key Players of Dabigatran Etexilate Mesylate API Upstream (Raw Materials)
Table 239. Dabigatran Etexilate Mesylate API Typical Customers
Table 240. Dabigatran Etexilate Mesylate API Typical Distributors
Table 1. World Dabigatran Etexilate Mesylate API Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Dabigatran Etexilate Mesylate API Production Value by Region (2018-2023) & (USD Million)
Table 3. World Dabigatran Etexilate Mesylate API Production Value by Region (2024-2029) & (USD Million)
Table 4. World Dabigatran Etexilate Mesylate API Production Value Market Share by Region (2018-2023)
Table 5. World Dabigatran Etexilate Mesylate API Production Value Market Share by Region (2024-2029)
Table 6. World Dabigatran Etexilate Mesylate API Production by Region (2018-2023) & (Tons)
Table 7. World Dabigatran Etexilate Mesylate API Production by Region (2024-2029) & (Tons)
Table 8. World Dabigatran Etexilate Mesylate API Production Market Share by Region (2018-2023)
Table 9. World Dabigatran Etexilate Mesylate API Production Market Share by Region (2024-2029)
Table 10. World Dabigatran Etexilate Mesylate API Average Price by Region (2018-2023) & (US$/Ton)
Table 11. World Dabigatran Etexilate Mesylate API Average Price by Region (2024-2029) & (US$/Ton)
Table 12. Dabigatran Etexilate Mesylate API Major Market Trends
Table 13. World Dabigatran Etexilate Mesylate API Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Tons)
Table 14. World Dabigatran Etexilate Mesylate API Consumption by Region (2018-2023) & (Tons)
Table 15. World Dabigatran Etexilate Mesylate API Consumption Forecast by Region (2024-2029) & (Tons)
Table 16. World Dabigatran Etexilate Mesylate API Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Dabigatran Etexilate Mesylate API Producers in 2022
Table 18. World Dabigatran Etexilate Mesylate API Production by Manufacturer (2018-2023) & (Tons)
Table 19. Production Market Share of Key Dabigatran Etexilate Mesylate API Producers in 2022
Table 20. World Dabigatran Etexilate Mesylate API Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 21. Global Dabigatran Etexilate Mesylate API Company Evaluation Quadrant
Table 22. World Dabigatran Etexilate Mesylate API Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Dabigatran Etexilate Mesylate API Production Site of Key Manufacturer
Table 24. Dabigatran Etexilate Mesylate API Market: Company Product Type Footprint
Table 25. Dabigatran Etexilate Mesylate API Market: Company Product Application Footprint
Table 26. Dabigatran Etexilate Mesylate API Competitive Factors
Table 27. Dabigatran Etexilate Mesylate API New Entrant and Capacity Expansion Plans
Table 28. Dabigatran Etexilate Mesylate API Mergers & Acquisitions Activity
Table 29. United States VS China Dabigatran Etexilate Mesylate API Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Dabigatran Etexilate Mesylate API Production Comparison, (2018 & 2022 & 2029) & (Tons)
Table 31. United States VS China Dabigatran Etexilate Mesylate API Consumption Comparison, (2018 & 2022 & 2029) & (Tons)
Table 32. United States Based Dabigatran Etexilate Mesylate API Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Dabigatran Etexilate Mesylate API Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Dabigatran Etexilate Mesylate API Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Dabigatran Etexilate Mesylate API Production (2018-2023) & (Tons)
Table 36. United States Based Manufacturers Dabigatran Etexilate Mesylate API Production Market Share (2018-2023)
Table 37. China Based Dabigatran Etexilate Mesylate API Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Dabigatran Etexilate Mesylate API Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Dabigatran Etexilate Mesylate API Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Dabigatran Etexilate Mesylate API Production (2018-2023) & (Tons)
Table 41. China Based Manufacturers Dabigatran Etexilate Mesylate API Production Market Share (2018-2023)
Table 42. Rest of World Based Dabigatran Etexilate Mesylate API Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Dabigatran Etexilate Mesylate API Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Dabigatran Etexilate Mesylate API Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Dabigatran Etexilate Mesylate API Production (2018-2023) & (Tons)
Table 46. Rest of World Based Manufacturers Dabigatran Etexilate Mesylate API Production Market Share (2018-2023)
Table 47. World Dabigatran Etexilate Mesylate API Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Dabigatran Etexilate Mesylate API Production by Type (2018-2023) & (Tons)
Table 49. World Dabigatran Etexilate Mesylate API Production by Type (2024-2029) & (Tons)
Table 50. World Dabigatran Etexilate Mesylate API Production Value by Type (2018-2023) & (USD Million)
Table 51. World Dabigatran Etexilate Mesylate API Production Value by Type (2024-2029) & (USD Million)
Table 52. World Dabigatran Etexilate Mesylate API Average Price by Type (2018-2023) & (US$/Ton)
Table 53. World Dabigatran Etexilate Mesylate API Average Price by Type (2024-2029) & (US$/Ton)
Table 54. World Dabigatran Etexilate Mesylate API Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Dabigatran Etexilate Mesylate API Production by Application (2018-2023) & (Tons)
Table 56. World Dabigatran Etexilate Mesylate API Production by Application (2024-2029) & (Tons)
Table 57. World Dabigatran Etexilate Mesylate API Production Value by Application (2018-2023) & (USD Million)
Table 58. World Dabigatran Etexilate Mesylate API Production Value by Application (2024-2029) & (USD Million)
Table 59. World Dabigatran Etexilate Mesylate API Average Price by Application (2018-2023) & (US$/Ton)
Table 60. World Dabigatran Etexilate Mesylate API Average Price by Application (2024-2029) & (US$/Ton)
Table 61. Hetero Drugs Ltd Basic Information, Manufacturing Base and Competitors
Table 62. Hetero Drugs Ltd Major Business
Table 63. Hetero Drugs Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 64. Hetero Drugs Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Hetero Drugs Ltd Recent Developments/Updates
Table 66. Hetero Drugs Ltd Competitive Strengths & Weaknesses
Table 67. Aurobindo Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 68. Aurobindo Pharma Ltd Major Business
Table 69. Aurobindo Pharma Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 70. Aurobindo Pharma Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Aurobindo Pharma Ltd Recent Developments/Updates
Table 72. Aurobindo Pharma Ltd Competitive Strengths & Weaknesses
Table 73. Neuland Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Neuland Laboratories Ltd Major Business
Table 75. Neuland Laboratories Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 76. Neuland Laboratories Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Neuland Laboratories Ltd Recent Developments/Updates
Table 78. Neuland Laboratories Ltd Competitive Strengths & Weaknesses
Table 79. Zydus Lifesciences Ltd Basic Information, Manufacturing Base and Competitors
Table 80. Zydus Lifesciences Ltd Major Business
Table 81. Zydus Lifesciences Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 82. Zydus Lifesciences Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Zydus Lifesciences Ltd Recent Developments/Updates
Table 84. Zydus Lifesciences Ltd Competitive Strengths & Weaknesses
Table 85. Alkem Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 86. Alkem Laboratories Ltd Major Business
Table 87. Alkem Laboratories Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 88. Alkem Laboratories Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Alkem Laboratories Ltd Recent Developments/Updates
Table 90. Alkem Laboratories Ltd Competitive Strengths & Weaknesses
Table 91. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 92. Teva Pharmaceutical Industries Ltd Major Business
Table 93. Teva Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 94. Teva Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 96. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 97. Lupin Ltd Basic Information, Manufacturing Base and Competitors
Table 98. Lupin Ltd Major Business
Table 99. Lupin Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 100. Lupin Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Lupin Ltd Recent Developments/Updates
Table 102. Lupin Ltd Competitive Strengths & Weaknesses
Table 103. Dr Reddys Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Dr Reddys Laboratories Ltd Major Business
Table 105. Dr Reddys Laboratories Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 106. Dr Reddys Laboratories Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Dr Reddys Laboratories Ltd Recent Developments/Updates
Table 108. Dr Reddys Laboratories Ltd Competitive Strengths & Weaknesses
Table 109. Apotex Pharmachem India Pvt Ltd Basic Information, Manufacturing Base and Competitors
Table 110. Apotex Pharmachem India Pvt Ltd Major Business
Table 111. Apotex Pharmachem India Pvt Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 112. Apotex Pharmachem India Pvt Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Apotex Pharmachem India Pvt Ltd Recent Developments/Updates
Table 114. Apotex Pharmachem India Pvt Ltd Competitive Strengths & Weaknesses
Table 115. Glenmark Life Sciences Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Glenmark Life Sciences Ltd Major Business
Table 117. Glenmark Life Sciences Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 118. Glenmark Life Sciences Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Glenmark Life Sciences Ltd Recent Developments/Updates
Table 120. Glenmark Life Sciences Ltd Competitive Strengths & Weaknesses
Table 121. Alembic Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 122. Alembic Pharmaceuticals Ltd Major Business
Table 123. Alembic Pharmaceuticals Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 124. Alembic Pharmaceuticals Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Alembic Pharmaceuticals Ltd Recent Developments/Updates
Table 126. Alembic Pharmaceuticals Ltd Competitive Strengths & Weaknesses
Table 127. Msn Laboratories Private Ltd Basic Information, Manufacturing Base and Competitors
Table 128. Msn Laboratories Private Ltd Major Business
Table 129. Msn Laboratories Private Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 130. Msn Laboratories Private Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Msn Laboratories Private Ltd Recent Developments/Updates
Table 132. Msn Laboratories Private Ltd Competitive Strengths & Weaknesses
Table 133. Metrochem Api Private Ltd Basic Information, Manufacturing Base and Competitors
Table 134. Metrochem Api Private Ltd Major Business
Table 135. Metrochem Api Private Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 136. Metrochem Api Private Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Metrochem Api Private Ltd Recent Developments/Updates
Table 138. Metrochem Api Private Ltd Competitive Strengths & Weaknesses
Table 139. Lee Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 140. Lee Pharma Ltd Major Business
Table 141. Lee Pharma Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 142. Lee Pharma Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Lee Pharma Ltd Recent Developments/Updates
Table 144. Lee Pharma Ltd Competitive Strengths & Weaknesses
Table 145. Msn Life Sciences Private Ltd Basic Information, Manufacturing Base and Competitors
Table 146. Msn Life Sciences Private Ltd Major Business
Table 147. Msn Life Sciences Private Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 148. Msn Life Sciences Private Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Msn Life Sciences Private Ltd Recent Developments/Updates
Table 150. Msn Life Sciences Private Ltd Competitive Strengths & Weaknesses
Table 151. Optimus Drugs Private Ltd Basic Information, Manufacturing Base and Competitors
Table 152. Optimus Drugs Private Ltd Major Business
Table 153. Optimus Drugs Private Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 154. Optimus Drugs Private Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Optimus Drugs Private Ltd Recent Developments/Updates
Table 156. Optimus Drugs Private Ltd Competitive Strengths & Weaknesses
Table 157. Yabao Pharmaceutical Group Co Ltd Basic Information, Manufacturing Base and Competitors
Table 158. Yabao Pharmaceutical Group Co Ltd Major Business
Table 159. Yabao Pharmaceutical Group Co Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 160. Yabao Pharmaceutical Group Co Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Yabao Pharmaceutical Group Co Ltd Recent Developments/Updates
Table 162. Yabao Pharmaceutical Group Co Ltd Competitive Strengths & Weaknesses
Table 163. Acebright India Pharma Private Ltd Basic Information, Manufacturing Base and Competitors
Table 164. Acebright India Pharma Private Ltd Major Business
Table 165. Acebright India Pharma Private Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 166. Acebright India Pharma Private Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Acebright India Pharma Private Ltd Recent Developments/Updates
Table 168. Acebright India Pharma Private Ltd Competitive Strengths & Weaknesses
Table 169. Srini Pharmaceuticals Private Ltd Basic Information, Manufacturing Base and Competitors
Table 170. Srini Pharmaceuticals Private Ltd Major Business
Table 171. Srini Pharmaceuticals Private Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 172. Srini Pharmaceuticals Private Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Srini Pharmaceuticals Private Ltd Recent Developments/Updates
Table 174. Srini Pharmaceuticals Private Ltd Competitive Strengths & Weaknesses
Table 175. Biocon Ltd Basic Information, Manufacturing Base and Competitors
Table 176. Biocon Ltd Major Business
Table 177. Biocon Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 178. Biocon Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. Biocon Ltd Recent Developments/Updates
Table 180. Biocon Ltd Competitive Strengths & Weaknesses
Table 181. Jubilant Generics Ltd Basic Information, Manufacturing Base and Competitors
Table 182. Jubilant Generics Ltd Major Business
Table 183. Jubilant Generics Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 184. Jubilant Generics Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 185. Jubilant Generics Ltd Recent Developments/Updates
Table 186. Jubilant Generics Ltd Competitive Strengths & Weaknesses
Table 187. Solara Active Pharma Sciences Ltd Basic Information, Manufacturing Base and Competitors
Table 188. Solara Active Pharma Sciences Ltd Major Business
Table 189. Solara Active Pharma Sciences Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 190. Solara Active Pharma Sciences Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 191. Solara Active Pharma Sciences Ltd Recent Developments/Updates
Table 192. Solara Active Pharma Sciences Ltd Competitive Strengths & Weaknesses
Table 193. Piramal Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 194. Piramal Pharma Ltd Major Business
Table 195. Piramal Pharma Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 196. Piramal Pharma Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 197. Piramal Pharma Ltd Recent Developments/Updates
Table 198. Piramal Pharma Ltd Competitive Strengths & Weaknesses
Table 199. Micro Labs Ltd Basic Information, Manufacturing Base and Competitors
Table 200. Micro Labs Ltd Major Business
Table 201. Micro Labs Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 202. Micro Labs Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 203. Micro Labs Ltd Recent Developments/Updates
Table 204. Micro Labs Ltd Competitive Strengths & Weaknesses
Table 205. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 206. Sun Pharmaceutical Industries Ltd Major Business
Table 207. Sun Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 208. Sun Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 209. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 210. Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 211. Zhejiang Huahai Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 212. Zhejiang Huahai Pharmaceutical Co Ltd Major Business
Table 213. Zhejiang Huahai Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 214. Zhejiang Huahai Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 215. Zhejiang Huahai Pharmaceutical Co Ltd Recent Developments/Updates
Table 216. Zhejiang Huahai Pharmaceutical Co Ltd Competitive Strengths & Weaknesses
Table 217. Sichuan Qingmu Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 218. Sichuan Qingmu Pharmaceutical Co Ltd Major Business
Table 219. Sichuan Qingmu Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 220. Sichuan Qingmu Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 221. Sichuan Qingmu Pharmaceutical Co Ltd Recent Developments/Updates
Table 222. Sichuan Qingmu Pharmaceutical Co Ltd Competitive Strengths & Weaknesses
Table 223. Jiangxi Synergy Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 224. Jiangxi Synergy Pharmaceutical Co Ltd Major Business
Table 225. Jiangxi Synergy Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 226. Jiangxi Synergy Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 227. Jiangxi Synergy Pharmaceutical Co Ltd Recent Developments/Updates
Table 228. Jiangxi Synergy Pharmaceutical Co Ltd Competitive Strengths & Weaknesses
Table 229. Changzhou Pharmaceutical Factory Basic Information, Manufacturing Base and Competitors
Table 230. Changzhou Pharmaceutical FactoryMajor Business
Table 231. Changzhou Pharmaceutical Factory Dabigatran Etexilate Mesylate API Product and Services
Table 232. Changzhou Pharmaceutical Factory Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 233. Changzhou Pharmaceutical Factory Recent Developments/Updates
Table 234. Hisun Pharmaceutical Nantong Co Ltd Basic Information, Manufacturing Base and Competitors
Table 235. Hisun Pharmaceutical Nantong Co Ltd Major Business
Table 236. Hisun Pharmaceutical Nantong Co Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 237. Hisun Pharmaceutical Nantong Co Ltd Dabigatran Etexilate Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 238. Global Key Players of Dabigatran Etexilate Mesylate API Upstream (Raw Materials)
Table 239. Dabigatran Etexilate Mesylate API Typical Customers
Table 240. Dabigatran Etexilate Mesylate API Typical Distributors
LIST OF FIGURES
Figure 1. Dabigatran Etexilate Mesylate API Picture
Figure 2. World Dabigatran Etexilate Mesylate API Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Dabigatran Etexilate Mesylate API Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Dabigatran Etexilate Mesylate API Production (2018-2029) & (Tons)
Figure 5. World Dabigatran Etexilate Mesylate API Average Price (2018-2029) & (US$/Ton)
Figure 6. World Dabigatran Etexilate Mesylate API Production Value Market Share by Region (2018-2029)
Figure 7. World Dabigatran Etexilate Mesylate API Production Market Share by Region (2018-2029)
Figure 8. North America Dabigatran Etexilate Mesylate API Production (2018-2029) & (Tons)
Figure 9. Europe Dabigatran Etexilate Mesylate API Production (2018-2029) & (Tons)
Figure 10. China Dabigatran Etexilate Mesylate API Production (2018-2029) & (Tons)
Figure 11. Japan Dabigatran Etexilate Mesylate API Production (2018-2029) & (Tons)
Figure 12. Dabigatran Etexilate Mesylate API Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Dabigatran Etexilate Mesylate API Consumption (2018-2029) & (Tons)
Figure 15. World Dabigatran Etexilate Mesylate API Consumption Market Share by Region (2018-2029)
Figure 16. United States Dabigatran Etexilate Mesylate API Consumption (2018-2029) & (Tons)
Figure 17. China Dabigatran Etexilate Mesylate API Consumption (2018-2029) & (Tons)
Figure 18. Europe Dabigatran Etexilate Mesylate API Consumption (2018-2029) & (Tons)
Figure 19. Japan Dabigatran Etexilate Mesylate API Consumption (2018-2029) & (Tons)
Figure 20. South Korea Dabigatran Etexilate Mesylate API Consumption (2018-2029) & (Tons)
Figure 21. ASEAN Dabigatran Etexilate Mesylate API Consumption (2018-2029) & (Tons)
Figure 22. India Dabigatran Etexilate Mesylate API Consumption (2018-2029) & (Tons)
Figure 23. Producer Shipments of Dabigatran Etexilate Mesylate API by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Dabigatran Etexilate Mesylate API Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Dabigatran Etexilate Mesylate API Markets in 2022
Figure 26. United States VS China: Dabigatran Etexilate Mesylate API Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Dabigatran Etexilate Mesylate API Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Dabigatran Etexilate Mesylate API Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Dabigatran Etexilate Mesylate API Production Market Share 2022
Figure 30. China Based Manufacturers Dabigatran Etexilate Mesylate API Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Dabigatran Etexilate Mesylate API Production Market Share 2022
Figure 32. World Dabigatran Etexilate Mesylate API Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Dabigatran Etexilate Mesylate API Production Value Market Share by Type in 2022
Figure 34. Purity?99%
Figure 35. Purity<99%
Figure 36. World Dabigatran Etexilate Mesylate API Production Market Share by Type (2018-2029)
Figure 37. World Dabigatran Etexilate Mesylate API Production Value Market Share by Type (2018-2029)
Figure 38. World Dabigatran Etexilate Mesylate API Average Price by Type (2018-2029) & (US$/Ton)
Figure 39. World Dabigatran Etexilate Mesylate API Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Dabigatran Etexilate Mesylate API Production Value Market Share by Application in 2022
Figure 41. Capsule
Figure 42. Others
Figure 43. World Dabigatran Etexilate Mesylate API Production Market Share by Application (2018-2029)
Figure 44. World Dabigatran Etexilate Mesylate API Production Value Market Share by Application (2018-2029)
Figure 45. World Dabigatran Etexilate Mesylate API Average Price by Application (2018-2029) & (US$/Ton)
Figure 46. Dabigatran Etexilate Mesylate API Industry Chain
Figure 47. Dabigatran Etexilate Mesylate API Procurement Model
Figure 48. Dabigatran Etexilate Mesylate API Sales Model
Figure 49. Dabigatran Etexilate Mesylate API Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Figure 1. Dabigatran Etexilate Mesylate API Picture
Figure 2. World Dabigatran Etexilate Mesylate API Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Dabigatran Etexilate Mesylate API Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Dabigatran Etexilate Mesylate API Production (2018-2029) & (Tons)
Figure 5. World Dabigatran Etexilate Mesylate API Average Price (2018-2029) & (US$/Ton)
Figure 6. World Dabigatran Etexilate Mesylate API Production Value Market Share by Region (2018-2029)
Figure 7. World Dabigatran Etexilate Mesylate API Production Market Share by Region (2018-2029)
Figure 8. North America Dabigatran Etexilate Mesylate API Production (2018-2029) & (Tons)
Figure 9. Europe Dabigatran Etexilate Mesylate API Production (2018-2029) & (Tons)
Figure 10. China Dabigatran Etexilate Mesylate API Production (2018-2029) & (Tons)
Figure 11. Japan Dabigatran Etexilate Mesylate API Production (2018-2029) & (Tons)
Figure 12. Dabigatran Etexilate Mesylate API Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Dabigatran Etexilate Mesylate API Consumption (2018-2029) & (Tons)
Figure 15. World Dabigatran Etexilate Mesylate API Consumption Market Share by Region (2018-2029)
Figure 16. United States Dabigatran Etexilate Mesylate API Consumption (2018-2029) & (Tons)
Figure 17. China Dabigatran Etexilate Mesylate API Consumption (2018-2029) & (Tons)
Figure 18. Europe Dabigatran Etexilate Mesylate API Consumption (2018-2029) & (Tons)
Figure 19. Japan Dabigatran Etexilate Mesylate API Consumption (2018-2029) & (Tons)
Figure 20. South Korea Dabigatran Etexilate Mesylate API Consumption (2018-2029) & (Tons)
Figure 21. ASEAN Dabigatran Etexilate Mesylate API Consumption (2018-2029) & (Tons)
Figure 22. India Dabigatran Etexilate Mesylate API Consumption (2018-2029) & (Tons)
Figure 23. Producer Shipments of Dabigatran Etexilate Mesylate API by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Dabigatran Etexilate Mesylate API Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Dabigatran Etexilate Mesylate API Markets in 2022
Figure 26. United States VS China: Dabigatran Etexilate Mesylate API Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Dabigatran Etexilate Mesylate API Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Dabigatran Etexilate Mesylate API Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Dabigatran Etexilate Mesylate API Production Market Share 2022
Figure 30. China Based Manufacturers Dabigatran Etexilate Mesylate API Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Dabigatran Etexilate Mesylate API Production Market Share 2022
Figure 32. World Dabigatran Etexilate Mesylate API Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Dabigatran Etexilate Mesylate API Production Value Market Share by Type in 2022
Figure 34. Purity?99%
Figure 35. Purity<99%
Figure 36. World Dabigatran Etexilate Mesylate API Production Market Share by Type (2018-2029)
Figure 37. World Dabigatran Etexilate Mesylate API Production Value Market Share by Type (2018-2029)
Figure 38. World Dabigatran Etexilate Mesylate API Average Price by Type (2018-2029) & (US$/Ton)
Figure 39. World Dabigatran Etexilate Mesylate API Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Dabigatran Etexilate Mesylate API Production Value Market Share by Application in 2022
Figure 41. Capsule
Figure 42. Others
Figure 43. World Dabigatran Etexilate Mesylate API Production Market Share by Application (2018-2029)
Figure 44. World Dabigatran Etexilate Mesylate API Production Value Market Share by Application (2018-2029)
Figure 45. World Dabigatran Etexilate Mesylate API Average Price by Application (2018-2029) & (US$/Ton)
Figure 46. Dabigatran Etexilate Mesylate API Industry Chain
Figure 47. Dabigatran Etexilate Mesylate API Procurement Model
Figure 48. Dabigatran Etexilate Mesylate API Sales Model
Figure 49. Dabigatran Etexilate Mesylate API Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
